US trials of Cardima's ablation catheter begin:
This article was originally published in Clinica
Executive Summary
The first US patient has been successfully treated for atrial fibrillation with Cardima's Pathfinder ablation catheter. The 38-year old man, who had been suffering AF episodes almost every day over five years, was treated with the catheter and left hospital with a normal heart rhythm. The treatment was part of a feasibility trial of the device - a PMA trial is set to begin before the year end. In Europe, 12 patients have been treated so far for AF.